Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DGKA | P23743 | 1/20 | 0.46 |
| ▸ | TSHR | P16473 | 2/20 | 0.43 |
| ▸ | LMNA | P02545 | 3/20 | 0.43 |
| ▸ | PAM | P19021 | 2/20 | 0.42 |
| ▸ | MAPT | P10636 | 2/20 | 0.41 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.41 |
| ▸ | CES2 | O00748 | 4/20 | 0.40 |
| ▸ | CES1 | P23141 | 4/20 | 0.40 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.39 |
| ▸ | DNM1 | Q05193 | 1/20 | 0.39 |
| ▸ | POLB | P06746 | 1/20 | 0.39 |
| ▸ | POLA1 | P09884 | 1/20 | 0.39 |
| ▸ | NAAA | Q02083 | 1/20 | 0.39 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.38 |
| ▸ | SLC22A8 | Q8TCC7 | 1/20 | 0.38 |
| ▸ | GPR84 | Q9NQS5 | 1/20 | 0.38 |
| ▸ | PPARG | P37231 | 1/20 | 0.38 |
| ▸ | PPARD | Q03181 | 1/20 | 0.38 |
| ▸ | PPARA | Q07869 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14914049 | 0.98 | DGKA (0.48) | DGKATSHRLMNAPAMMAPT | |
| SCHEMBL1025349 | 0.98 | DGKA (0.48) | DGKATSHRLMNAPAMMAPT | |
| SCHEMBL28232708 | 0.98 | DGKA (0.48) | DGKATSHRLMNAPAMMAPT | |
| SCHEMBL2308844 | 0.94 | DGKA (0.38) | DGKATSHRLMNAPAMMAPT | |
| SCHEMBL3252650 | 0.86 | ALDH1A1 (0.44) | TSHRCES2CES1ALDH1A1 | |
| SCHEMBL28080240 | 0.80 | DGKA (0.42) | DGKATSHRLMNAPAMMAPT | |
| SCHEMBL22557779 | 0.80 | DGKA (0.44) | DGKATSHRLMNAPAMMAPT | |
| SCHEMBL15708072 | 0.79 | LMNA (0.53) | DGKATSHRLMNAPAMMAPT | |
| SCHEMBL11662066 | 0.79 | — | — | |
| SCHEMBL451966 | 0.78 | DGKA (0.54) | DGKATSHRLMNAPAMMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 130 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220409526-A1 | COMPOUNDS AND IMPLANTS FOR TREATING OCULAR DISORDERS | RETINA FOUND OF THE SOUTHWEST (US) | 2022-12-29 | — | — | US | claimed |
| US-20220409526-A1 | COMPOUNDS AND IMPLANTS FOR TREATING OCULAR DISORDERS | RETINA FOUND OF THE SOUTHWEST (US) | 2022-12-29 | — | — | US | disclosed |
| CN-112741816-A | Novel colon drug delivery system | 江苏集萃新型药物制剂技术研究所有限公司 | 2021-05-04 | — | — | CN | disclosed |
| CN-211122902-U | Vehicle-mounted alcohol tester | 四川工商学院 | 2020-07-28 | — | — | CN | disclosed |
| CN-111372950-A | VEGFR-antibody light chain fusion proteins | 免疫苏醒公司 | 2020-07-03 | — | — | CN | disclosed |
| CN-111214701-A | Implants for localized drug delivery and methods of use thereof | 加利福尼亚大学董事会 | 2020-06-02 | — | — | CN | disclosed |
| EP-2171021-B1 | USE OF A CONDUCTIVITY IMPROVER IN A HYDROCARBON COMPOSITION | INNOSPEC LTD (GB) | 2020-04-01 | — | — | EP | disclosed |
| CN-106573133-B | Implants for localized drug delivery and methods of use thereof | 加利福尼亚大学董事会 | 2020-03-03 | — | — | CN | disclosed |
| EP-2102317-B1 | ADDITIVE, FUEL COMPOSITION, METHOD AND USE | INNOSPEC LTD (GB) | 2018-10-17 | — | — | EP | disclosed |
| EP-1640438-B1 | Improvements in Fuel Oils | INFINEUM INT LTD (GB) | 2017-08-30 | — | — | EP | disclosed |
| WO-1996028523-A1 | FUEL OIL ADDITIVES AND COMPOSITIONS | EXXON CHEMICAL PATENTS INC. (US) | 1996-09-19 | — | — | WO | disclosed |
| WO-1996022344-A1 | FUEL OIL COMPOSITIONS | EXXON CHEMICAL LIMITED (GB) | 1996-07-25 | — | — | WO | disclosed |
| EP-0721492-A1 | ADDITIVES AND FUEL COMPOSITIONS | EXXON CHEMICAL PATENTS INC. (US) | 1996-07-17 | — | — | EP | disclosed |
| WO-1996018707-A1 | FUEL OIL COMPOSITIONS | EXXON CHEMICAL PATENTS INC. (US) | 1996-06-20 | — | — | WO | disclosed |
| WO-1996018708-A1 | FUEL OIL COMPOSITIONS | EXXON CHEMICAL PATENTS INC. (US) | 1996-06-20 | — | — | WO | disclosed |
| WO-1996018706-A1 | FUEL OIL COMPOSITIONS | EXXON CHEMICAL PATENTS INC. (US) | 1996-06-20 | — | — | WO | disclosed |
| WO-1995033805-A1 | FUEL OIL COMPOSITIONS | EXXON CHEMICAL PATENTS INC. (US) | 1995-12-14 | — | — | WO | disclosed |
| WO-1995033021-A1 | OIL ADDITIVES AND COMPOSITIONS | EXXON CHEMICAL PATENTS INC. (US) | 1995-12-07 | — | — | WO | disclosed |
| WO-1995003377-A1 | ADDITIVES AND FUEL COMPOSITIONS | EXXON CHEMICAL PATENTS INC. (US) | 1995-02-02 | — | — | WO | disclosed |
| WO-1994017159-A1 | OIL AND FUEL OIL COMPOSITIONS | EXXON CHEMICAL PATENTS INC. (US) | 1994-08-04 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220409526-A1 | COMPOUNDS AND IMPLANTS FOR TREATING OCULAR DISORDERS | PDE6C, STRA6, PDE6A | DGKA 2035/4885TSHR 1021/4885LMNA 3239/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.